Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 871 AL 885

Regulated neuronal death in Alzheimer's disease: Crosstalk and convergence of apoptosis, pyroptosis, senescence, and ferroptosis

Zhang Y, Zhang D, Xiao H.

J Alzheimers Dis. 2026 May;111(1):32-55. doi: 10.1177/13872877261430002. Epub 2026 Mar 11.

The glymphatic system as a brain scavenger in Alzheimer's disease: mechanisms and therapeutic implications

Zheng M, Su W, Tian L, Gao W.

Brain Res. 2026 Jun 1;1880:150221. doi: 10.1016/j.brainres.2026.150221. Epub 2026 Feb 26.

Molecular Mechanisms Underlying Alzheimer's Disease Pathogenesis: Comprehensive Overview

Lo Vecchio F, la Torre A, Gravina C, D'Onofrio G, Greco A.

Int J Mol Sci. 2026 May 21;27(10):4651. doi: 10.3390/ijms27104651.

PANoptosis in Alzheimer's disease: The expanding landscape of programmed cell death mechanisms and therapeutic interventions

Paidlewar M, Kumari S, Dhapola R, Sharma P, Vellingiri B, Medhi B, HariKrishnaReddy D.

Free Radic Biol Med. 2026 Jul;250:80-98. doi: 10.1016/j.freeradbiomed.2026.03.053. Epub 2026 Mar 20.

Irisin as an Exerkine of Neuroprotection in Aging and Alzheimer's Disease

White ZJ, Hall SE.

Biomolecules. 2026 May 6;16(5):687. doi: 10.3390/biom16050687.

Targeting Lipid Metabolism in Alzheimer's Disease: Emerging Insights and Future Directions

Balakrishnan J, Kannan S, Shanmugam K, Sugasini D.

J Integr Neurosci. 2026 Apr 21;25(4):48436. doi: 10.31083/JIN48436.

Protein Modifications and Quality Control System: Target for Alzheimer's Disease Therapy

Sheikh AM, Yano S, Tabassum S, Bhuiya J, Nagai A.

Int J Mol Sci. 2026 May 11;27(10):4266. doi: 10.3390/ijms27104266.

NAD(+) Homeostasis and Mitochondrial Modifiability: Resilience in Alzheimer's Disease

Stefano GB.

Front Biosci (Landmark Ed). 2026 Mar 19;31(3):49714. doi: 10.31083/FBL49714.

Effect of Physical Activity on Cognitive Function of Patients With Alzheimer's Disease: A Meta-analysis

Dai S, Yuan S, Zhang X, Zhong X, Jiang C.

J Integr Neurosci. 2026 Jan 26;25(1):42702. doi: 10.31083/JIN42702.

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure

Banerjee G, Mok TH, Hyare H, Cousins O, Jaunmuktane Z, Mead S, Collinge J.

JAMA Neurol. 2026 May 1;83(5):435-441. doi: 10.1001/jamaneurol.2026.0437.

Lecanemab and Donanemab Combination Therapy for Alzheimer's Disease-The Cocktail May Work Even Better Together

Dinnerstein E.

Alzheimer Dis Assoc Disord. 2026 Jan-Mar 01;40(1):65-66. doi: 10.1097/WAD.0000000000000711. Epub 2026 Feb 24.

Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease

Rae RJ, Alberhasky JMH, Baillet M, Bangasser DA, Belloy ME, Berry AS, Berteotti C, Bow H, Buckley R, Caldwell JZK, Carpi M, Clark BJ, Ciampa CJ, Conley AC, Dahl MJ, Donaldson ZR, Ehrenberg AJ, Einstein G, Falgàs N, Fenlon HA, Fitzhugh MC, Froemke RC, Gallay C, Grinberg LT, Hamilton DA, Hasan Z, Huarte OU, Jabeen S, Jacobs HIL, Kolling LJ, Koops EA, Lenzoni S, Liguori C, Manca R, Marcinkiewcz CA, Omoluabi T, Oria R, Orsini CA, Ortega NE, Pa J, Pentkowski NS, Pereira JB, Ramos R, Sargin D, Satpati A, Selles MC, Seto M, Shaik SM, Sindi S, Son G, Ucheagwu V, Van Egroo M, Yuan Q, Kelberman MA.

Alzheimers Dement. 2026 Mar;22(3):e71291. doi: 10.1002/alz.71291.

Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review

Jiang X, Lv G, Xiong X, Yuan J, Kevin Lu Z.

J Alzheimers Dis. 2026 May;111(1):102-114. doi: 10.1177/13872877261430376. Epub 2026 Mar 16.

Targeting STAT3 in Alzheimer's disease: Potential mechanisms and therapeutic implications

Chen P, Wang R, Zhou T, Sun Y, Kirchhoff F, Miao Z, Zhuang C.

Eur J Med Chem. 2026 Jun 5;310:118785. doi: 10.1016/j.ejmech.2026.118785. Epub 2026 Mar 18.

Unknotting the Role of circRNAs and IGF2BP3 in Alzheimer's Disease

Firdous SM, Jayathilaka SNS, Marick S, Porel P.

Cell Mol Neurobiol. 2026 Apr 16;46(1):94. doi: 10.1007/s10571-026-01724-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias